Lightlake Therapeutics Inc. (OTCBB: LLTP) (the âCompanyâ, âWeâ or âLightlakeâ), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Companyâs Phase II clinical trial ...
[Published BioSpace - May 23 2013]